Cargando…
Fatal Renal Bleeding in a Patient Treated With Aggressive Antithrombotic Therapy After Recurrent Coronary Stent Thrombosis
Triple antiplatelet therapy has been known to be superior to the conventional dual regimen for preventing stent thrombosis after coronary stenting, and the addition of oral anticoagulation to antiplatelet therapy is also considered an option. However, the risks and benefits of a triple antiplatelet...
Autores principales: | Moon, Jeonggeun, Lee, Sang-Hak, Yang, Woo-In, Ko, Young-Guk, Han, Woong Kyu, Jang, Yangsoo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910293/ https://www.ncbi.nlm.nih.gov/pubmed/20664745 http://dx.doi.org/10.4070/kcj.2010.40.7.348 |
Ejemplares similares
-
Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis
por: Menozzi, Mila, et al.
Publicado: (2012) -
Coronary Stent Infection Presented as Recurrent Stent Thrombosis
por: Lai, Chih-Hung, et al.
Publicado: (2017) -
A Newly Formed and Ruptured Atheromatous Plaque within Neointima after Drug-Eluting Stent Implantation: 2-Year Follow-Up Intravascular Ultrasound and Optical Coherence Tomography Studies
por: Oh, Chang-Myung, et al.
Publicado: (2011) -
Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation After Coronary Stent Implantation
por: Jang, Sung-Won, et al.
Publicado: (2011) -
Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation
por: Hong, Sung-Jin, et al.
Publicado: (2015)